Tombak, A; Tanrikulu, FP; Durusoy, SS; Dincyurek, HD; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocamaz, V; Gunes, AK; Sahip, B; Ertop, S; Akay, OM; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Gurkan, E; Cekdemir, D; Ferhanoglu, B
(2021)
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...